Disappointing news from a trial of the AstraZeneca vaccine against the South African variant of COVID-19 will further complicate vaccination campaigns across the region, and could delay recoveries further. In South Africa, the annual State of the Nation Address (SONA) recounted many of the government’s previously outlined plans to recover from the coronavirus crisis but offered few new initiatives to support the economy.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services